⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL107046 | 0.96 | CA1 (0.30) | — | |
| SCHEMBL6104435 | 0.93 | — | — | |
| SCHEMBL3981221 | 0.93 | — | — | |
| SCHEMBL3981218 | 0.93 | — | — | |
| SCHEMBL6104433 | 0.90 | — | — | |
| Lithium Ion SCHEMBL3794395 | 0.90 | — | — | |
| SCHEMBL5956692 | 0.87 | — | — | |
| SCHEMBL31135471 | 0.84 | ADRB2 (0.41) | — | |
| Diethylamine SCHEMBL27875040 | 0.82 | TP53 (0.44) | — | |
| SCHEMBL5090577 | 0.80 | ADRB2 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE39151-E1 | Process for the preparation and purification of thiol-containing maytansinoids | IMMUNOGEN, INC. (US) | 2006-06-27 | — | — | US | claimed |
| EP-1313738-B1 | PROCESS FOR THE PREPARATION AND PURIFICATION OF THIOL-CONTAINING MAYTANSINOIDS | IMMUNOGEN INC (US) | 2005-12-21 | — | — | EP | claimed |
| EP-1313738-A4 | PROCESS FOR THE PREPARATION AND PURIFICATION OF THIOL-CONTAINING MAYTANSINOIDS | IMMUNOGEN INC (US) | 2005-01-19 | — | — | EP | claimed |
| EP-1313738-A1 | PROCESS FOR THE PREPARATION AND PURIFICATION OF THIOL-CONTAINING MAYTANSINOIDS | Immunogen, Inc. (US) | 2003-05-28 | — | — | EP | claimed |
| WO-2002016368-A1 | PROCESS FOR THE PREPARATION AND PURIFICATION OF THIOL-CONTAINING MAYTANSINOIDS | IMMUNOGEN, INC. (US) | 2002-02-28 | — | — | WO | claimed |
| US-6333410-B1 | REDUCTIVE HYDROLYSIS OF C3 ESTER WITH LITHIUM TRIMETHOXYALUMINUM HYDRIDE TO YIELD THE MANTANSINOL; ESTERIFYING THE A DISULFIDE-CONTAINING CARBOXYLIC ACID; REDUCING TO YIELD A THIOL-CONTAINING MAYTANSINOID | IMMUNOGEN, INC. | 2001-12-25 | — | — | US | claimed |
| WO-2016018934-A1 | BIOMARKERS AND MORPHOLOGY BASED APTAMER SELECTION OF SAME | COMPANION DX REFERENCE LAB, LLC (TEXAS) (US) | 2016-02-04 | — | — | WO | disclosed |
| US-7767803-B2 | Stabilized aptamers to PSMA and their use as prostate cancer therapeutics | ARCHEMIX CORP. (US) | 2010-08-03 | — | — | US | disclosed |
| US-20090105172-A1 | Stabilized Aptamers to PSMA and Their Use as Prostate Cancer Therapeutics | ARCHEMIX CORP. | 2009-04-23 | — | — | US | disclosed |
| EP-1863828-A2 | STABILIZED APTAMERS TO PSMA AND THEIR USE AS PROSTATE CANCER THERAPEUTICS | Archemix Corp. (US) | 2007-12-12 | — | — | EP | disclosed |
| EP-1756318-A2 | APTAMER-TOXIN MOLECULES AND METHOD FOR USING SAME | Archemix Corporation (US) | 2007-02-28 | — | — | EP | disclosed |
| US-20070041901-A1 | Stabilized aptamers to PSMA and their use as prostate cancer therapeutics | ARCHEMIX CORP. | 2007-02-22 | — | — | US | disclosed |
| WO-2006096754-A2 | STABILIZED APTAMERS TO PSMA AND THEIR USE AS PROSTATE CANCER THERAPEUTICS | ARCHEMIX CORP. (US) | 2006-09-14 | — | — | WO | disclosed |
| EP-1313738-A1 | PROCESS FOR THE PREPARATION AND PURIFICATION OF THIOL-CONTAINING MAYTANSINOIDS | Immunogen, Inc. (US) | 2003-05-28 | — | — | EP | disclosed |
| US-20020156274-A1 | Process for preparing maytansinol | SMITHKLINE BEECHAM CORPORATION | 2002-10-24 | — | — | US | disclosed |
| WO-2002074775-A1 | PROCESS FOR PREPARING MAYTANSINOL | SMITHKLINE BEECHAM CORPORATION (US) | 2002-09-26 | — | — | WO | disclosed |
| WO-2002016368-A1 | PROCESS FOR THE PREPARATION AND PURIFICATION OF THIOL-CONTAINING MAYTANSINOIDS | IMMUNOGEN, INC. (US) | 2002-02-28 | — | — | WO | disclosed |
| WO-2002016368-A1 | PROCESS FOR THE PREPARATION AND PURIFICATION OF THIOL-CONTAINING MAYTANSINOIDS | IMMUNOGEN, INC. (US) | 2002-02-28 | — | — | WO | disclosed |
| US-6333410-B1 | REDUCTIVE HYDROLYSIS OF C3 ESTER WITH LITHIUM TRIMETHOXYALUMINUM HYDRIDE TO YIELD THE MANTANSINOL; ESTERIFYING THE A DISULFIDE-CONTAINING CARBOXYLIC ACID; REDUCING TO YIELD A THIOL-CONTAINING MAYTANSINOID | IMMUNOGEN, INC. | 2001-12-25 | — | — | US | disclosed |
| US-6333410-B1 | REDUCTIVE HYDROLYSIS OF C3 ESTER WITH LITHIUM TRIMETHOXYALUMINUM HYDRIDE TO YIELD THE MANTANSINOL; ESTERIFYING THE A DISULFIDE-CONTAINING CARBOXYLIC ACID; REDUCING TO YIELD A THIOL-CONTAINING MAYTANSINOID | IMMUNOGEN, INC. | 2001-12-25 | — | — | US | disclosed |